X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Nath Bio-Genes (India) Ltd.
BSE CODE: 537291   |   NSE CODE: NATHBIOGEN   |   ISIN CODE : INE448G01010   |   17-Sep-2025 Hrs IST
BSE NSE
Rs. 168.00
-0.1 ( -0.06% )
 
Prev Close ( Rs.)
168.10
Open ( Rs.)
166.50
 
High ( Rs.)
169.75
Low ( Rs.)
166.50
 
Volume
1694
Week Avg.Volume
2669
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 166.89
-0.31 ( -0.19% )
 
Prev Close ( Rs.)
167.20
Open ( Rs.)
168.49
 
High ( Rs.)
168.50
Low ( Rs.)
166.00
 
Volume
10426
Week Avg.Volume
12422
 
52 WK High-Low Range(Rs.)
137.55
238.69
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)22.17  21.14  18.50  -35.43  29.29  
   CEPS(Rs)24.17  22.86  20.09  -33.81  30.77  
   DPS(Rs)2.00  2.00  2.00  2.00  2.00  
   Book NAV/Share(Rs)341.33  321.33  301.70  285.19  322.71  
   Tax Rate(%)4.50  4.62  3.17  -6.23  1.92  
Margin Ratios          
   Core EBITDA Margin(%)14.46  15.17  16.31  13.39  21.71  
   EBIT Margin(%)14.87  15.43  15.49  -18.95  21.33  
   Pre Tax Margin(%)12.18  12.66  12.05  -22.77  18.45  
   PAT Margin (%)11.63  12.08  11.67  -24.19  18.10  
   Cash Profit Margin (%)12.68  13.06  12.67  -23.08  19.01  
Performance Ratios          
   ROA(%)4.45  4.81  4.59  -8.81  7.33  
   ROE(%)6.69  6.79  6.31  -11.66  9.51  
   ROCE(%)7.29  7.34  7.11  -7.82  9.78  
   Asset Turnover(x)0.38  0.40  0.39  0.36  0.41  
   Sales/Fixed Asset(x)1.31  1.22  1.12  1.04  1.16  
   Working Capital/Sales(x)1.14  1.08  0.99  1.02  0.85  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.76  0.82  0.89  0.96  0.87  
   Receivable days92.25  105.14  110.76  127.81  128.40  
   Inventory Days281.97  239.72  259.37  292.83  255.51  
   Payable days-262.02  -1432.06  744.29  1663.14  -1472.04  
Valuation Parameters          
   PER(x)6.58  8.22  7.66  0.00  10.24  
   PCE(x)6.03  7.60  7.05  -6.31  9.75  
   Price/Book(x)0.43  0.54  0.47  0.75  0.93  
   Yield(%)1.37  1.15  1.41  0.94  0.67  
   EV/Net Sales(x)0.83  1.09  1.12  1.78  2.09  
   EV/Core EBITDA(x)5.26  7.10  6.77  12.63  9.37  
   EV/EBIT(x)5.58  7.07  7.21  -9.37  9.78  
   EV/CE(x)0.40  0.50  0.50  0.67  0.81  
   M Cap / Sales0.77  0.99  0.89  1.46  1.85  
Growth Ratio          
   Net Sales Growth(%)8.92  10.40  8.24  -9.49  9.89  
   Core EBITDA Growth(%)11.74  2.90  27.00  -42.83  20.87  
   EBIT Growth(%)4.99  9.94  188.50  -180.38  18.95  
   PAT Growth(%)4.89  14.25  152.22  -220.98  10.26  
   EPS Growth(%)4.89  14.25  152.22  -220.98  10.26  
Financial Stability Ratios          
   Total Debt/Equity(x)0.17  0.18  0.18  0.17  0.16  
   Current Ratio(x)1.87  2.18  2.40  2.41  3.10  
   Quick Ratio(x)0.96  1.30  1.44  1.27  1.79  
   Interest Cover(x)5.52  5.58  4.51  -4.96  7.40  
   Total Debt/Mcap(x)0.40  0.33  0.39  0.23  0.18